References
- Basturk B, Karasu Z, Kilic M, et al (2008). Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol, 8, 20-5. https://doi.org/10.1016/j.meegid.2007.09.001
- Beck J, Nassal M (2007). Hepatitis B virus replication. World J Gastroenterol, 13, 48-64. https://doi.org/10.3748/wjg.v13.i1.48
- Ben-Ari Z, Mor E, Papo O, et al (2003). Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol, 98, 144-50. https://doi.org/10.1111/j.1572-0241.2003.07179.x
- Chanthra N, Payungporn S, Chuaypen N, et al (2015). Single Nucleotide Polymorphisms in STAT3 and STAT4 and risk of hepatocellular carcinoma in Thai patients with chronic hepatitis B. Asian Pac J Cancer Prev, 16, 8405-10.
- Di Bisceglie AM (2009). Hepatitis B And Hepatocellular Carcinoma. Hepatol, 49, 56-60. https://doi.org/10.1002/hep.22962
- Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
- Hajiani E, Masjedizadeh R, Hashemi J, et al (2005). Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J, 26, 974-7.
- Jeng JE, Wu HF, Tsai MF, et al (2014). Independent and additive interaction between tumor necrosis factor beta +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study. Asian Pac J Cancer Prev, 15, 10209-15.
- Kay A, Zoulim F (2007). Hepatitis B virus genetic variability and evolution. Virus Res, 127, 164-76. https://doi.org/10.1016/j.virusres.2007.02.021
- Kim YJ, Lee HS, Yoon JH, et al (2003). Association of TNFalpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet, 12, 2541-6. https://doi.org/10.1093/hmg/ddg262
- Kumar V, Abbas AK, Fausto N, et al (2014). Robbins and cotran pathologic basis of disease, Elsevier Health Sci, 27.
- Kummee P, Tangkijvanich P, Poovorawan Y, et al (2007). Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat, 14, 841-8.
- Li N, Gao YF, Zhang TC, et al (2012). Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol, 4, 105-9. https://doi.org/10.4254/wjh.v4.i3.105
- Limothai U, Wasitthankasem R, Poovorawan Y, et al (2015). Single nucleotide polymorphism of interferon lambda-4 gene is not associated with treatment response to pegylated interferon in Thai patients with chronic hepatitis B. Asian Pac J Cancer Prev, 16, 5515-9. https://doi.org/10.7314/APJCP.2015.16.13.5515
- Locksley RM, Killeen N, Lenardo MJ (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104, 487-501. https://doi.org/10.1016/S0092-8674(01)00237-9
- Mansoori M, Golalipour M, Alizadeh S, et al (2015). Genetic variation in the ABCB1 gene may lead to mRNA level chabge: application to gastric cancer cases. Asian Pac J Cancer Prev, 16, 8467-71.
- Merat S, Malekzadeh R, Rezvan H, et al (2000). Hepatitis B in Iran. Arch Iran Med, 3, 192-201.
- Nun-Anan P, Chonprasertsuk S, Siramolpiwat S, et al (2015). CYP2C19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis B infection in Thailand. Asian Pac J Cancer Prev, 16, 3253-6. https://doi.org/10.7314/APJCP.2015.16.8.3253
- Pourhoseingholi MA, Fazeli Z, Zali MR, et al (2010). Burden of hepatocellular carcinoma in Iran; bayesian projection and trend analysis. Asian Pac J Cancer Prev, 11, 859-62.
- Pungpapong S, Kim WR, Poterucha JJ (2007). Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc, 82, 967-75. https://doi.org/10.4065/82.8.967
- Seeger C, Mason WS (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev, 64, 51-68. https://doi.org/10.1128/MMBR.64.1.51-68.2000
- Shamszad M, Farzadegan H (1982). Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran. J Irn Med Council, 8, 238.
- Somi MH, Najafi L, Noori BN, et al (2006). Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol, 25, 14-5.
- Tayebi S, Mohamadkhani A (2012). The TNF-alpha -308 promoter gene polymorphism and chronic HBV Infection. Hepat Res Treat, 2012, 493219.
- Wang B, Wang J, Zheng Y, et al (2010). A study of TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathol, 42, 674-80. https://doi.org/10.3109/00313025.2010.523696
- Wang C, Tang J, Song W, et al (2004). HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatol, 39, 978-88. https://doi.org/10.1002/hep.20142
- Wang CH, Wey KC, Mo LR, et al (2015). Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev, 16, 3595-604. https://doi.org/10.7314/APJCP.2015.16.9.3595
- Wirz SA, Morale MC, Marchetti B, et al (2004). High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia. Cytokine, 26, 149-54. https://doi.org/10.1016/j.cyto.2004.02.006
- Xu XW, Lu MH, Tan DM (2005). Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect, 11, 52-6. https://doi.org/10.1111/j.1469-0691.2004.01029.x
- Zheng MH, Qiu LX, Xin YN, et al (2010). Tumor necrosis factoralpha- 308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis, 14, 580-5. https://doi.org/10.1016/j.ijid.2009.08.010
- Zuckerman AJ (1996). Hepatitis viruses. in 'medical microbiology', eds university of texas medical branch at galveston. The University of Texas Medical Branch at Galveston, Galveston (TX).